Showing 1 - 2 results of 2 for search 'Ming-zhe Xiao', query time: 0.02s Refine Results
  1. 1
    Case Report: Adjuvant Crizotinib Therapy Exerted Favorable Survival Benefit in a Resectable Stage IIIA NSCLC Patient With Novel LDLR–ROS1 Fusion

    Case Report: Adjuvant Crizotinib Therapy Exerted Favorable Survival Benefit in a Resectable Stage IIIA NSCLC Patient With Novel LDLR–ROS1 Fusion by An-guo Chen, Dong-sheng Chen, Dong-sheng Chen, Dong-sheng Chen, Si Li, Si Li, Si Li, Le-le Zhao, Le-le Zhao, Le-le Zhao, Ming-zhe Xiao, Ming-zhe Xiao, Ming-zhe Xiao

    Published 2022-03-01
    Get full text
    Article
  2. 2
    NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer

    NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer by Xiao-yang Gong, Hai-bin Chen, Li-qing Zhang, Dong-sheng Chen, Wang Li, Dong-hui Chen, Jin Xu, Han Zhou, Le-le Zhao, Yun-jie Song, Ming-zhe Xiao, Wang-long Deng, Chuang Qi, Xue-rong Wang, Xi Chen

    Published 2022-07-01
    Get full text
    Article

Search Tools: